Precision Medicine

Galectin Therapeutics adds legendary neurosurgeon Dr. Henry Brem to its board, a strategic move to leverage his drug development expertise for its lead liver drug.

Princess Padmaja Kumari Parmar receives the Mary Tyler Moore Award for her advocacy, bridging a legacy of hope with a modern fight for global T1D equity.

The biotech reports promising clinical data for its lead alpha-therapy program and secures funding into late 2027, navigating a high-cost, high-reward path.

With promising clinical data for its lead drug silevertinib and a strong new financial position, Black Diamond Therapeutics charts a dual course for two deadly cancers.

A new prenatal vitamin tackles the 'choline gap,' a nutrient deficiency affecting 90% of pregnant women that is crucial for fetal brain development.

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.

As maternity care deserts expand, one rural hospital is using wearable tech to bring vital prenatal monitoring to high-risk mothers right in their homes.

From experimental surgeries to robotic precision, see how UCHealth's 60-year journey transformed organ transplantation and gave 10,000 people a new life.

A partnership between Biophytis and LynxKite leverages AI to fast-track therapies for sarcopenia and macular degeneration, backed by Singapore's RIE 2030 plan.

As employers grapple with soaring obesity drug costs, a new partnership aims to offer predictable pricing and comprehensive care. Here's how it works.

With a $35 million boost from RA Capital, Equillium extends its cash runway to 2029, fueling the clinical development of its promising oral UC therapy, EQ504.

At SXSW, Reckitt Catalyst and Serena Williams unveil a new cohort of U.S. entrepreneurs tackling America's deep-rooted healthcare access crisis.

A legislative movement across 11 states aims to make scalp cooling, a therapy to prevent hair loss during chemo, an insured part of cancer treatment.

A landmark review decodes how ketogenic diets treat epilepsy, highlighting a major research gap and sparking a quest for drugs that mimic the diet's effects.

One year post-approval, Neurotech's novel gene therapy implant is transforming patient lives and rewriting the playbook for biotech commercialization.

A global campaign is rebranding the canned sardine as a weapon against metabolic disease. We investigate the science, the strategy, and a $12 wellness plan.

A groundbreaking clinical trial shows a nutrition-based therapy extended life by 34% in stage IV pancreatic cancer patients, offering rare hope.

New research shows a telehealth model boosting GLP-1 results to over 26% weight loss, but its reliance on unapproved compounded drugs raises safety flags.

The specialty infusion provider is the first to earn a rigorous new distinction, signaling a major leap forward in patient safety and quality of care.

A plant-based gel that stops severe bleeding in seconds is being showcased to top trauma experts, signaling a major shift in emergency medicine.